The statements of the chief exec and the deputy chief exec are correct. The current scientific and medical evidence does not support the wholesale testing of asymptomatic ambulance staff. If it did, we would shift our position and make sure that we have the capacity deployed in accordance with that advice. The surveillance testing of care home staff has been something that has provided confidence in the sector, and meant that we have been able to deliver not just the testing for people that go into residential care, in particular when discharged from hospital, but that the staff themselves feel protected and we've been able to understand where outbreaks are taking place. The special vulnerability of care home residents is a different factor to the way that paramedics undertake their jobs and the range of people they come into contact with. It’s also a fact that we don't see the same level of staff change within direct contact when it comes to the ambulance service and dealing with people within the community. That isn't really a comparable position to the regular teams of people that need to care for people in care homes. It is the case that if the evidence changes, we will, of course, be happy to shift our position. There's nothing inconsistent with the current policy decision and the best, most up-to-date scientific evidence and advice.